Heart Transplant Survivor Fights to Keep Access to Anti Rejection Drug Payton Herres's health insurer, Anthem, effectively held her life hostage over a medication that keeps her donor heart functioning.
This shocking episode is one symptom of a deeper malady afflicting the US healthcare system – an out of control obsession with cost cutting at the expense of patient well being.
Herres's ordeal began when Anthem unilaterally decided to stop covering everolimus, a critical component of her anti rejection medication regimen.